http://www.the-iacp.com/CBTBR.html Copyright 2011 by the International Association for Cognitive Psychotherapy Regulation approach in enhancing mastery rather than simply reducing symptoms. Given Portman"s clear command of this literature, an even greater emphasis on this aspect of the chapter would be valuable, particularly to beginning clinicians who may grapple with the question of how to approach treatment planning with clients presenting with a chronic course of excessive worry, or how best to respond in the not unlikely case of suboptimal response to first line treatments.
In Chapter 5, Pharmacotherapy, Portman presents a comprehensive review of evidencebased medication interventions as well as a brief overview of the genetic and neurobiological underpinnings of this disorder. Portman offers a flexible assessment of the contested question of benzodiazepine use to treat anxiety symptoms, stating that despite the recent trend away from BZ monotherapy, this class of medications may still play a role in treating those with chronic or primarily somatic symptoms. He provides a thorough review of the evidence base for first line SNRI and SSRI treatment, the "favored choice" in both the short and long term management of GAD symptoms. This chapter also discusses the emerging data on pregabalin as the "ideal anxiolytic" (Frampton & Foster, 2006) due to its rapid onset, low side effect profile, and utility in addressing somatic symptoms and secondary insomnia. Into a chapter that would easily lend itself to an exhaustive documentation of the various medication trials, Portman also weaves higher-order concepts, such as the ethical question of administering medications that produce "artificial happiness" but do not address the chasm between current and ideal circumstances. In doing so, Portman challenges the reader to consider not only pharmacological efficacy but also the broader implications of medication use.
Special Populations (Chapter 6) discusses the distinct clinical presentation and assessment, diagnosis, and treatment considerations for children and adolescents as well as older adults. This important chapter alerts the reader to significant differences in the manifestation and effective management of generalized anxiety symptoms across the lifespan. Portman highlights the changing nature of worry content from childhood to older adulthood, and presents evidence suggesting that while psychosocial treatments appear to offer an advantage over pharmacological approaches in younger cohorts, the inverse appears to be true for older adults. Given the evidence presented that GAD is the most common psychological disorder among both of these cohorts, further research is clearly warranted to address the unique challenges of treating worry at different life stages.
In Enigmas and Paradoxes (Chapter 7), the reader is introduced to several areas where significant gaps in the literature exist. Portman correctly identifies the paucity of literature on prevention of GAD, and suggests the need for more conceptual models and evidence-based education in this area. In his exploration of cross-cultural considerations, Portman highlights the difference between somatic and psychological presentations of excessive worry, and puts forward the novel perspective that perhaps given the prevalence of somatization among worriers, it is Western, rather than non-Western cultures, that require explication. Finally, the book comes full circle to discuss the issue of treatment resistance that was first raised in Chapter 1. This section focuses largely on medication (atypical antipsychotic) augmentation given the relative absence of psychosocial treatment studies that address this topic, but also presents yet-to-be addressed options including family involvement, couples therapy, the use of community or religious resources, self-help, and exercise. Portman does justice to this chapter despite the current lack of empirical literature that addresses these important questions.
In the final chapter, Future Directions and Recommendations (Chapter 8), Portman provides a vision of the future of GAD treatment and research. There is a brief discussion of the
